Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8236341 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 7 Pages |
Abstract
CA 19-9 decline shows a correlation with radiologic response. The combination of pretreatment CA 19-9 >1,200 U/mL, posttreatment CA 19-9 >100 U/mL, and CA 19-9 decline â¤40% may possibly serve as a surrogate marker for poor survival in advanced PC receiving chemoradiotherapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Woong Sub M.D., Jinsil M.D., Yong Bae M.D., Hae Ok B.S., Si Young M.D.,